A critical review on bismuth oxyhalide based photocatalysis for pharmaceutical active compounds degradation: Modifications, reactive sites, and challenges.

Pharmaceutical active compounds (PhACs), as a kind of widely used pharmaceutical drugs, has attracted much attention. The bismuth oxyhalides (BiOX)-based photocatalysis can remove PhACs efficiently due to its unique layered structure, optical and electronic properties. Nevertheless, the rapid recombination of photogenerated electron-hole pairs, and the inherent instability of structure have limited its practical application.